CUBE vs ICCC · P/E 25, rev $1.07B vs rev $26.5M
CubeSmart (CUBE) versus ImmuCell Corporation (ICCC) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. ICCC currently screens at market cap $58.9M.
Not investment advice. Open the CUBE and ICCC stock pages for the full models.
Not investment advice.